Table of Contents
What is COVID-19?
On 31 December 2019, World Health Organization (WHO) was alerted to several cases of pneumonia in Wuhan City, Hubei Province of China. The virus did not match any other known virus. On 7 January, Chinese authorities confirmed that they had identified a new virus. The new virus is a coronavirus, which is a family of viruses that include the common cold, and viruses such as SARS and MERS. This new virus was temporarily named “2019-nCoV”, and later was renamed COVID-19. It may also be referred to as Wuhan Virus or Wuhan novel coronavirus (WN-CoV).
COVID-19 has spread to a number of countries around the world. This is how it is being searched on Google globally and in the US:
Transmission of COVID-19
COVID-19 first cases associated with live animal market in Wuhan, China suggest initial animal-to-human spillover. COVID-19 is transmitted person-to-person between close contacts (within 6 feet) via respiratory droplets produced with an infected person coughs or sneezes. Contact with fomites may be possible, but it is not thought to be the primary route of transmission
Infected persons are thought to be most contagious when they are most symptomatic, though some spread may be possible before showing symptoms.
Most people (about 80%) recover from the disease without needing special treatment. Around 1 out of every 6 people who gets COVID-19 becomes seriously ill and develops difficulty breathing. Older people, and those with underlying medical problems like high blood pressure, heart problems or diabetes, are more likely to develop serious illness.
Follow global transmission data on J Hopkins Hospital website.
Symptoms of COVID-19
People may experience:
- – Runny nose
- – Sore throat
- – Cough
- – Fever
- – Pneumonia
- – Difficulty breathing (severe cases)
People with fever, cough and difficulty breathing should seek medical attention.
Nature, the leading international weekly journal of science, reports NIH and several other centers are expecting to launch vaccine trials. As of April 2020 there is no vaccine and no specific antiviral medicine available. The most effective ways to protect yourself and others against COVID-19 are to frequently clean your hands, cover your cough with the bend of elbow or tissue, and maintain a distance of at least 1 meter (3 feet) from people who are coughing or sneezing. (See WHO’s Basic protective measures against the new coronavirus).
While a facemask may be effective in blocking splashes and large-particle droplets, a facemask, by design, does not filter or block very small particles in the air that may be transmitted by coughs, sneezes or certain medical procedures. Facemasks also do not provide complete protection from germs and other contaminants because of the loose fit between the surface of the facemask and your face. Only wear a mask if you are ill with COVID-19 symptoms (especially coughing) or looking after someone who may have COVID-19.
If you are going to buy a face mask then look for something more advanced. In US this means N95 or even N99, N100 and P100 designated respirators which are certified by the US National Institute for Occupational Safety and Health.
In Europe EN-149 is one of the European Standard for masks. Consider FFP2 or FFP3 level masks. FFP2 dust masks protect against moderate levels of dust, as well as solid and liquid aerosols. FFP2 Dust Masks have a higher level of protection than FFP1. FFP3 dust masks protect against higher levels of dust. They also protect against solid and liquid aerosols. FFP3 masks are suitable for handling hazardous powders, such as those found in the pharmaceutical industry.
NOTE: Disposable face mask can only be used once. If you are not ill or looking after someone who is ill then you are wasting a mask. There is a world-wide shortage of masks, so WHO urges people to use masks wisely.
Effects of COVID-19 on business and supply chains.
Nearly 75% of companies have reported supply chain disruptions as a result of COVID-19, according to a new survey released by the Institute for Supply Management (ISM). The ISM announced Wednesday (March 11) the first-round results of a survey focused on the effects of COVID-19 on business and supply chains.
More than 80% of companies expect to experience some impact because of COVID-19 disruptions, the survey shows. Of those, 16% have adjusted revenue targets downward an average of 5.6% because of the virus.
Companies reported the following impacts:
- – 57% noted longer lead times for tier-1 China-sourced components, with average lead times more than doubling compared to the end of 2019.
- – Manufacturers in China report operating at 50% capacity with 56% of normal staff.
- – More than 44% of respondents don’t have a plan to address supply disruptions from China. Of those, 23% report existing disruptions.
- – The companies that report supply chain impacts expect the severity to rise after the first quarter of 2020.
- – 62% are experiencing delays in receiving orders from China.
- – More than half are having difficulty receiving supply chain information from China.
- – 48% are experiencing delays moving goods within China.
- – Nearly half report delays loading goods at ports in China.
Transit Routes in Europe
Countries in Europe have been closing their borders since mid March 2020 to stop the spread of the virus. All countries still allow transit of goods although there can be serious waiting times on the borders. As of 19. March 2020 most countries in Europe limit private travels.
Rethink Your Supply Chain
Waredock a leading cross border on-demand warehousing and scalable distribution network with services such as warehouse storage, ecommerce fulfillment, retail fulfillment, shipping and more. We operate in 9+ European countries and have partner network in the USA.
Access to Waredock will help merchants and 3PL suppliers connect quickly and effectively, and minimize disruption caused by shipment delays, capacity issues and increased consumer demand in times of crisis. We can help make the connections to keep the supply chain intact, that ultimately have an impact on the everyday consumer.
Sign up today as a buyer or 3PL. You can post immediate sourcing needs and 3PL suppliers can respond to show they can deliver. Free to post. Free to respond. Open to everyone.
Key Resources For Updates
Use the following resources to get latest updates about the outbreak:
- Johns Hopkins University Center for Systems Science and Engineering dashboard reports cases at the province level in China; at the city level in the USA, Australia, and Canada; and at the country level otherwise.
- World Health Organization (WHO): https://www.who.int/
- Comparison of COVID-19 trajectories worldwide https://biit.cs.ut.ee/covid/#/trajectories
- National Health Commission of the People’s Republic of China (NHC):http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml
- China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm
- Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html
- Taiwan CDC: https://sites.google.com/cdc.gov.tw/2019ncov/taiwan?authuser=0
- US CDC: https://www.cdc.gov/coronavirus/2019-ncov/index.html
- Government of Canada: https://www.canada.ca/en/public-health/services/diseases/coronavirus.html
- Australia Government Department of Health: https://www.health.gov.au/news/coronavirus-update-at-a-glance
- European Centre for Disease Prevention and Control (ECDC): https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases
- Ministry of Health Singapore (MOH): https://www.moh.gov.sg/covid-19
- Italy Ministry of Health: http://www.salute.gov.it/nuovocoronavirus